Skip Navigation
Skip to contents

Ann Clin Nutr Metab : Annals of Clinical Nutrition and Metabolism

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Sarcopenic obesity"
Filter
Filter
Article category
Keywords
Publication year
Authors
Review Article
Effect of Sarcopenia in Patients after Pancreatectomy
In Woong Han
Surg Metab Nutr 2018;9(2):31-35.   Published online December 30, 2018
DOI: https://doi.org/10.18858/smn.2018.9.2.31
AbstractAbstract PDFePub

Sarcopenia is characterized as a syndrome involving the progressive or generalized loss of skeletal muscle mass and strength with or without increased fat mass. This is one of well-known risk factors for adverse treatment outcomes in patients with various medical and surgical diseases. Sarcopenia itself, independent of the body mass index, is a powerful prognostic factor for cancer cachexia, liver cirrhosis, and even all causes of mortality. In terms of gastrointestinal surgery, sarcopenia is a significant prognostic factor in patients with gastric or colorectal cancers. Sarcopenia is related to postoperative complication, 30-day mortality, overall survival, and disease-free survival after gastrointestinal surgery. For patients with hepatic surgery, sarcopenia is also a significant prognostic factor. Several studies, including meta-analysis, proved sarcopenia to be waiting-list mortality and post-transplantation mortality in liver transplantation patients. Similarly, preoperative sarcopenic obesity was an independent risk factor for death and hepatocellular carcinoma recurrence after a hepatectomy. In cases of pancreatic cancer, several studies proposed that sarcopenia was an objective measure of patient frailty that was strongly associated with the long-term outcome independent of tumor-specific factors. In addition, sarcopenia or sarcopenic obesity has been reported to be a strong predictor of major complications after pancreatectomy. As a result, sarcopenia could be used to improve patient selection before a pancreatectomy. The next step to solve the questions to manage sarcopenia and improve the post-pancreatectomy outcomes would be to determine the role of nutrition and physical activity in the prevention or treatment of sarcopenia, and to develop specific medications with an evidence-based treatment of sarcopenia in patients with pancreatectomy.

Citations

Citations to this article as recorded by  
  • Major Surgery in Sarcopenic Patients
    Kyung Won Seo
    Surgical Metabolism and Nutrition.2019; 10(1): 5.     CrossRef
  • 140 View
  • 0 Download
  • 1 Crossref
Close layer

Ann Clin Nutr Metab : Annals of Clinical Nutrition and Metabolism
Close layer
TOP